Black Diamond Therapeutics, Inc. (BDTX) vs Caribou Biosciences, Inc. (CRBU)
A side-by-side comparison of Black Diamond Therapeutics, Inc. and Caribou Biosciences, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
BDTX
Black Diamond Therapeutics, Inc.
$1.87HealthcareDelayed quote: Oct 6, 2026, 10:10 AM EDT
CRBU
Caribou Biosciences, Inc.
$1.19HealthcareDelayed quote: Oct 6, 2026, 10:10 AM EDT
Total return — BDTX vs CRBU
growth of $100 · dividends reinvested · last 5yBDTX -80.4% (-27.8%/yr)CRBU -92.7% (-40.8%/yr)BDTX compounded faster over this window
BDTX CRBU
BDTX vs CRBU: by the numbers
- •CRBU is the larger company ($118M vs $107M market cap).
- •BDTX is profitable (31.95% net margin) while CRBU runs a net loss (-1030.42%).
Metrics side by side
Valuation
| Metric | BDTX | CRBU |
|---|---|---|
| P/S ratio | N/A | 11.72 |
| P/B ratio | 1.12 | 1.20 |
Profitability
| Metric | BDTX | CRBU |
|---|---|---|
| Gross margin | 99.54% | 67.34% |
| Operating margin | 28.39% | -1220.49% |
| Net margin | 31.95% | -1030.42% |
| ROE | -44.29% | -105.40% |
| ROIC | -47.54% | -87.72% |
Growth (annualized)
| Metric | BDTX | CRBU |
|---|---|---|
| Revenue CAGR (5Y) | N/A | -2.03% |
| Total return CAGR (5Y) | -24.47% | -44.43% |
Frequently asked
- Is BDTX or CRBU more profitable?
- BDTX runs the higher net margin — BDTX at 31.95% versus CRBU at -1030.42%.
- How have BDTX and CRBU total returns compared?
- Over the past 5 years, BDTX delivered -24.47% and CRBU delivered -44.43% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.